HomeEndocrinology
Endocrinology
Germany mulls reimbursing weight-loss drugs costs
In June, France became the first country in the European Union to start reimbursing the costs of weight-loss drugs like Ozempic and Wegovy for...
GLP-1 drugs may hold few benefits beyond physical health – US study
GLP-1 medications like Ozempic have transformed the treatment of type 2 diabetes, helping millions of patients better control their blood sugar while reducing cardiovascular...
Better weight loss from bariatric surgery than Ozempic, Zepbound – US study
A real-world study recently published in Obesity found that bariatric surgery may confer greater long-term weight loss than semaglutide or tirzepatide for adults with...
Low overall risk of vision loss with GLP-1 RA use – large Swedish cohort study
A nationwide study in Sweden has suggested only a slightly higher risk for non-arteritic anterior ischaemic optic neuropathy (NAION) among users of glucagon-like peptide-1...
What HIV got right, but obesity still hasn’t
As thousands of scientists, activists and policymakers gather in Rio de Janeiro for the 26th International Aids Conference this week, much of the discussion will...
Changing faces of Botticelli's muse hold clue to how she died 550 years ago
Simonetta Vespucci is probably one of the most painted women of the Italian Renaissance, widely believed to have been used by painter Sandro Botticelli...
Diabetics twice as likely to have hearing loss – Australian review
Researchers led by a team in Brisbane have suggested that adults with type 2 diabetes are more than twice as likely to develop clinically...
UK experts welcome new diabetes-delaying drug for NHS
A first-of-its-kind therapy that can delay type 1 diabetes for up to three years will soon be available across the UK, after the approval by the...
Higher BMI boosts risk of 19 cancers – global review
A sweeping analysis of 1.5m cancer cases shows that excess body weight may shape cancer risk more broadly than previously recognised, with risks varying...
Call for action as diabetes now leading cause of natural deaths
Tens of thousands of South Africans are dying annually from diabetes-related illnesses, the Diabetes Alliance has revealed after its review of mortality data released...
Experts warn of dangers with teleheath shopping for GLP-1s
Weight loss drugs may be easy to buy online, but growing overdose and safety concerns have prompted health professionals to issue fresh warnings and...
Why rebranding PCOS as PMOS is not ideal
A well-intentioned and recent name change may have unintended consequences, argue Kendall Soucie and Devika Bhushan in MedPage Today, after the name of a...
Ozempic may be reshaping the brain, scientists say
GLP-1 drugs may be rewiring circuits involved not only in appetite but in emotion, desire and beyond, reports The Washington Post.
Ozempic was supposed to...
New name, new focus for PCOS
Experts hope that renaming a condition that can often affect women’s fertility and diabetes risk – and which, in numerous cases, goes undiagnosed –...
Diabetes could drain $5trn from world economy – Chinese study
New modelling shows that apart from the obvious health threat, diabetes is also a major long-term economic threat, with disability, treatment costs and lost...
First global gene therapy trial for type 1 diabetes to start this year
The first-ever clinical trial of an adeno-associated virus (AAV) gene therapy for type 1 diabetes (T1D) will begin this year, aiming to promote insulin...
FDA approves first Farxiga generics for type 2 diabetes
The first generic of dapagliflozin (Farxiga) tablets for adults with type 2 diabetes has been given the green light by the US Food &...
Why some people don’t shed kilos with GLP-1 drugs – US study
Two genes involved in gut hormones that influence appetite and digestion may be a factor in how people respond to weight loss drugs, according...
Weekly hormone jab boosts growth of small-for-age children – US study
Most children born small for gestational age (SGA) experience catch-up growth in the first few years of life. However, at least 10% do not,...
Certain seniors can drop thyroid meds – Dutch study
An open-label prospective study by Netherlands researchers found that a quarter of older adults on hypothyroidism medication were able to wean off the drug...
FDA approves Lilly’s weight-loss pill in just 50 days
The FDA has expedited approval for Eli Lilly’s new weight-loss pill, which works like widely used injectable medications to mimic a natural hormone that...
Weight-loss treatment on brink of another dramatic shift
Just 10 weeks after approval from the US Food and Drug Administration, the Wegovy weight-loss pill is now estimated to be part of the daily...
Weight-gain fears after stopping Ozempic unfounded – Cleveland Clinic study
Stopping popular weight-loss injections like Ozempic or Mounjaro might not trigger the dramatic kilogram-laden rebound many fear, according to a study of nearly 8...
Recalled glucose monitor linked to seven deaths
A manufacturing problem in millions of Abbott glucose sensors has been tied to at least seven deaths and hundreds of injuries worldwide, reports NBC...
Under 7.32 hours' sleep ideal for glucose disposal – Chinese study
A cross-sectional study led by researchers from Nantong University in China and published in BMJ Open Diabetes Research & Care found that just under...
Why obesity should be treated as a chronic disease in South Africa
One in every three adult South Africans is obese, and yet the condition is not treated as a chronic disease in this country –...
Semaglutide shows heart benefits in key group – global study
An analysis by an international team of researchers has concluded that taking oral semaglutide may reduce heart-related hospitalisations and deaths among those with a...
Danish study links obesity to dementia risk
Obesity in midlife may cause vascular dementia later in life by raising blood pressure over decades and damaging brain vessels, according to research from a...
People who stop weight-loss jabs regain weight in two years – UK study
A landmark study, led by researchers from Oxford University, has found that people who stop taking weight loss jabs regain all of the weight...
How effective is intermittent fasting for health benefits?
The notion behind intermittent fasting is supposedly simple: eat less for a time and improve your metabolism, but the reality is more complex, suggest...
FDA green-lights Wegovy weight-loss pill
The US Food & Drug Administration (FDA) has approved the first oral glucagon-like peptide-1 (GLP-1) receptor agonist for weight loss and to reduce the...
New obesity drug delivers higher weight loss reduced knee pain
Eli Lilly’s next generation obesity drug has delivered the highest weight loss yet in a late stage trial while reducing knee arthritis pain, clearing...
Medical schemes barrier to SA’s costly obesity crisis
A huge chunk of healthcare spending in South Africa goes towards obesity, yet most medical schemes still limit cover for effective treatments – while...
SA regulators battle to stem tide of illicit weight loss jabs
The booming trade in black market weight loss drugs in South Africa is spiralling, with authorities seemingly unable to plug the sources or prevent...
New quick scan could hasten high BP diagnosis, treatment – UK study
A 10-minute scan could improve how millions of people with high blood pressure are treated, suggests a study led by University College London researchers...
Push to declare diabetes a public health emergency
Civil society organisations are intensifying calls for President Cyril Ramaphosa to declare diabetes a public health emergency, citing the need for urgent government intervention...
Rise in CKD linked to other chronic conditions – US study
The number of adults with chronic kidney disease is growing, according to a recent study published in The Lancet, which suggests the statistics might...
First obesity guideline for SA as experts flag growing burden
Obesity is reaching alarming proportions in South Africa, experts write, warning that apart from the potential health risks – heart disease, cancer, stroke, diabetes...
Future of male contraception under spotlight at French congress
Male contraception, a long-standing and confidential research topic, is gaining momentum. Hormonal, non-hormonal and reversible surgical methods are advancing rapidly, reflecting the growing demand...
SAHPRA grants Mounjaro jab approval for weight loss
Aspen Pharmacare has received approval from the SA Health Products Regulatory Authority (SAHPRA) for the diabetes treatment drug Mounjaro (tirzepatide) as a chronic weight...